HighTower Advisors
LSTA icon

HighTower Advisors’s Lisata Therapeutics LSTA Stock Holding History

HighTower Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.3K Hold
10,042
– – ﹤0.01% 3706
2025
Q4 		$18.7K Hold
10,042
– – ﹤0.01% 3615
2025
Q3 		$26.3K Hold
10,042
– – ﹤0.01% 3652
2025
Q2 		$29.1K Hold
10,042
– – ﹤0.01% 3589
2025
Q1 		$23.6K Hold
10,042
– – ﹤0.01% 3509
2024
Q4 		$29.9K Hold
10,042
– – ﹤0.01% 3507
2024
Q3 		$30K Sell
10,042
-2
-0% -$6 ﹤0.01% 3475
2024
Q2 		$35K Hold
10,044
– – ﹤0.01% 3350
2024
Q1 		$31K Hold
10,044
– – ﹤0.01% 3310
2023
Q4 		$27K Hold
10,044
– – ﹤0.01% 3373
2023
Q3 		$21K Buy
10,044
+2
+0% +$6 ﹤0.01% 3324
2023
Q2 		$37K Buy
+10,042
New +$36.5K ﹤0.01% 3198

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HighTower Advisors's LSTA Position: Q1 2026 in Review

HighTower Advisors held its Lisata Therapeutics (LSTA) position steady in Q1 2026 at 10,042 shares worth $50.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3706.

HighTower Advisors first reported a position in LSTA in Q2 2023 and has held it in 12 quarters since. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • HighTower Advisors held 10,042 shares of Lisata Therapeutics worth $50.3K as of Q1 2026.
  • HighTower Advisors left its Lisata Therapeutics share count unchanged in Q1 2026.
  • Lisata Therapeutics made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3706 holding.
  • HighTower Advisors first reported a position in Lisata Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.